What Changed
Price Move History
- Daily moves over 5%
- 45 252 sessions, November 13, 2025 to November 13, 2026
- Largest daily move
- -30.5% close of October 15, 2026
- 1-year change
- -61.8% closing prices, November 13, 2025 to November 13, 2026
- 1-month change
- -37.3% closing prices, October 13, 2026 to November 13, 2026
Company Description
FMC Corporation (NYSE: FMC) is a global agricultural sciences company that focuses on crop protection and related technologies. According to the company’s public disclosures, FMC is dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. The company operates in the pesticide and other agricultural chemical manufacturing industry and develops crop protection solutions that are used across a variety of crops and agronomic practices.
FMC describes its portfolio as centered on crop protection solutions, including biologicals, crop nutrition, and digital and precision agriculture. These offerings are designed to help growers and crop advisers address agronomic challenges in an economical way while protecting the environment. The company states that it is committed to discovering new herbicide, insecticide and fungicide active ingredients, as well as new product formulations and technologies that it characterizes as better for the planet.
In its communications, FMC emphasizes research and development of new active ingredients and technologies. Examples referenced in recent company news include Isoflex active, a herbicide active ingredient, and branded products such as Fundatis herbicide powered by Isoflex active, which has received registration in Great Britain for use in winter wheat and winter barley. The company also highlights branded products and actives such as Rynaxypyr active and Cyazypyr products, as well as a Plant Health business that includes biologicals.
FMC reports that it serves growers in multiple regions, including North America, Latin America, Asia and EMEA (Europe, Middle East and Africa). Company disclosures describe sales trends and competitive dynamics in these regions, including the impact of generic competition and regional demand patterns. FMC also reports on its growth portfolio, which includes new active ingredients such as fluindapyr and Isoflex active, and distinguishes this from its core portfolio.
FMC’s public statements indicate that the company manages its business in part through a pipeline of new active ingredients and technologies. It has described its pipeline of new active ingredients as central to its strategy and as a key growth engine for the company. The company also notes that its Plant Health business has grown, including contributions from biological products.
FMC is headquartered in Philadelphia, Pennsylvania, as indicated in its SEC filings. Its common stock trades on the New York Stock Exchange under the ticker symbol FMC. The company files periodic and current reports with the U.S. Securities and Exchange Commission, including Forms 10-K, 10-Q and 8-K, which provide additional detail on its operations, financial performance, restructuring activities and governance.
Business focus and operations
Based on the company’s own descriptions, FMC’s business is focused on agricultural crop protection and related technologies. Its product and technology areas include:
- Crop protection solutions, which encompass herbicide, insecticide and fungicide products.
- Biologicals, which are part of its Plant Health business and contribute to crop protection and nutrition.
- Crop nutrition, which supports plant growth and yield.
- Digital and precision agriculture, which are used by growers and crop advisers to manage agronomic decisions.
The company notes that its solutions are intended to help growers manage issues such as herbicide resistance and competitive pressure from weeds and pests. For example, FMC has highlighted Fundatis herbicide powered by Isoflex active as a new tool for resistance management in cereals in Great Britain, and has discussed the role of Isoflex active and other actives in managing key grass and broadleaf weeds.
Geographic and portfolio context
FMC’s disclosures describe its revenue and business performance by region, including North America, Latin America, Asia and EMEA. The company has discussed factors such as generic competition in Latin America and Asia, destocking in certain markets, and growth in EMEA driven by herbicides, diamide partners and branded products. It has also reported on its intention to divest its India commercial business while maintaining active ingredient manufacturing operations in India and supplying patented and data-protected products to the buyer under a supply agreement.
Within its portfolio, FMC distinguishes between a growth portfolio—which includes newer active ingredients such as fluindapyr and Isoflex active—and a core portfolio of legacy products. The company has reported growth in its growth portfolio and has discussed competitive pressures on some non-diamide legacy products.
Strategic initiatives and restructuring
In an 8-K filing, FMC reported that its Board of Directors approved a comprehensive plan referred to as Project Foundation to further optimize the company’s cost structure and organizational operations. A key component is a Manufacturing Restructuring Program focused on redesigning the manufacturing footprint, including exiting certain high-cost active ingredient and formulation plants and transitioning production to lower-cost sources. The company states that these actions are intended to create a cost-competitive structure that enables its products to better compete with generics while fully leveraging its technology portfolio.
FMC has also disclosed cost-reduction initiatives in Asia to reflect the smaller scale of the region’s business following the planned sale of the India commercial operations, as well as ongoing efforts to right-size its cost base and optimize its organizational structure. The company has reported that it expects Project Foundation to deliver annual run-rate savings when fully implemented and that it anticipates restructuring charges and asset write-offs associated with the program.
Capital structure, credit arrangements and dividends
Through an 8-K filing, FMC disclosed that it entered into an amendment to its Fifth Amended and Restated Credit Agreement. The amendment modifies certain financial covenants, extends a covenant relief period, and places limits on subsidiary indebtedness and increases to the regular quarterly dividend above a specified level, subject to leverage ratio conditions. The amendment also includes provisions related to the value of certain qualifying intellectual property and potential liens over assets under specified credit rating conditions.
FMC’s news releases indicate that the company’s Board of Directors has declared regular quarterly dividends and, in a separate release, has reduced the quarterly dividend as part of a broader response to business challenges and to prioritize debt reduction. The company notes that any future dividend is payable only when declared by the Board.
Earnings reporting and investor communications
FMC regularly announces the timing of its quarterly earnings releases and webcast conference calls. The company provides details for internet broadcasts and telephone dial-in access, and typically offers replays for a limited period. In its earnings releases, FMC reports revenue, net income or loss, adjusted EBITDA, adjusted earnings per share and other metrics, and discusses factors such as pricing, volume, foreign currency impacts, regional performance and portfolio dynamics.
The company also participates in investor conferences, as reflected in announcements that its senior executives speak at events such as the Goldman Sachs Industrials and Materials Conference and the Jefferies Industrials Conference. These events are accompanied by webcasts accessible through the company’s investor relations site.
Governance and leadership updates
FMC’s 8-K filings and news releases provide information on changes in leadership and board composition. For example, the company has reported the planned departure of its president and the resignation of a member of its Board of Directors due to external professional commitments and scheduling conflicts. These disclosures provide insight into governance developments and executive transitions.
Use of trademarks and regulatory context
FMC identifies various trademarks associated with its products and technologies, including FMC, the FMC logo, Isoflex, Fundatis, Rynaxypyr and Cyazypyr. The company notes that products may not be registered for sale or use in all states, countries or jurisdictions and emphasizes the importance of reading and following all label directions, restrictions and precautions for use. This reflects the regulatory environment in which agricultural chemical and crop protection products are developed, registered and marketed.
Stock Performance
FMC Corporation (FMC) closed at $5.21 on November 13, 2026. Over the past 12 months, the price has lost 61.8%.
FMC Metrics & Rankings
Price returns through November 13, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
FMC Corporation has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, earnings date, management, earnings, dividends. View all FMC news →
SEC Filings
FMC Corporation has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G/A, 2 Form 4, 1 Form 144, 1 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all FMC SEC filings →
Insider Radar
Insider selling at FMC Corporation over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
FMC Corporation generated $3.5B in revenue in FY2025, retaining a 37.0% gross margin, operating income reached -$1.6B (-47.0% operating margin), and net income was -$2.2B, reflecting a -64.6% net profit margin. Diluted earnings per share stood at -$17.88. The company generated -$6.2M in operating cash flow. The current ratio was 1.32, measuring current assets divided by current liabilities.
Upcoming Events
Anticipated Sofero Frugi approval
Product launches begin
EU Isoflex product launch
Lock-up expiration
First commercial sales
FMC Corporation has 5 upcoming scheduled events. The next event, "Anticipated Sofero Frugi approval", is expected in 2027. Investors can track these dates to stay informed about potential catalysts that may affect the FMC stock price.
Short Interest History
Short interest in FMC Corporation (FMC) currently stands at 38.4 million shares, up 26.0% from the previous reporting period, representing 31.2% of the float. Since November 2025, short interest has increased by 211.2%.
Days to Cover History
Days to cover for FMC Corporation (FMC) currently stands at 3.8 days, down 6.4% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 45%. Across the settlements charted above, it has ranged from 2.3 to 11.5 days.
FMC Company Profile & Sector Positioning
FMC Corporation (FMC) operates in the Agricultural Inputs industry within the broader Basic Materials sector and is listed on the NYSE. Among dividend-paying stocks, FMC ranks #467 by dividend yield.
Investors comparing FMC often look at related companies in the same sector, including CVR Partners, LP (UAN), Intrepid Potash, Inc (IPI), Corteva, Inc. (CTVA), The Mosaic Company (MOS), and ICL Group Ltd. (ICL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FMC's relative position within its industry.